HOME > Investors > Press Releases
2018-05-30
ViroMed Announces Publication of VM202’s MoA in Nerve Regeneration
2018-05-23
VM BioPharma Presents at Pain Therapeutics Conference in UK
2018-05-18
Reyon’s Lawsuit Dismissed by Court
2018-05-15
Five Korean Companies’ Stocks Join MSCI Index
2018-05-10
Global Market Report Forecasts ViroMed’s VM202 Will Become First Disease-Modifying Drug for PDPN
1 2 3 4 5 6 7 8 9 10